SUPPORT A CURE FOR DIABETES - WordPress.com · CURE FOR DIABETES Denise Faustman, MD, PhD, has spent the last decade researching a cure for type 1 diabetes. This work led her to discover

For more information on Dr. Faustman’s research, please visit www.faustmanlab.org.

SUPPORT ACURE FORDIABETES

Denise Faustman, MD, PhD, has spent the last decade researching a cure for type 1 diabetes. This work led her to discover a novel way to treat type 1 diabetes, accomplishing for the fi rst time ever the permanent reversal of established diabetes in mice.

Dr. Faustman is expanding this promising research to human applications and will hopefully one day cure type 1 diabetes.

Dr. Faustman is the director of the Immuno-biology Laboratory at Massachusetts General Hospital (MGH) and an associate professor of medicine at Harvard Medical School. Dr. Faustman became an independent investigator at MGH and Harvard Medical School in 1987. She completed her internship, residency, and fellowships in Internal Medicine and Endocrinology at MGH. She is also a member of the American Association for the Advancement of Science and serves as a frequent member of the Institute of Medicine.

Dr. Denise Faustman

I would like to give:

❒ $1,000 ❒ $500

❒ $250 ❒ $100

❒ $50 ❒ $

Payment Method:

please make your check out to “massachusetts General Hospital” and include “Cure diabetes Now fund” on the memo line. please mail to: massachusetts General Hospital development offi ce Attn: Jocelyn Hoey 165 Cambridge street, suite 600 Boston, mA 02114

Your gift is tax-deductible to the extent provided by law.

❒ please charge my credit card

❒ visA ❒ masterCard ❒ AmeX

Name on card:

Credit card #:

expiration date:

❒ my check is enclosed

Name:

Address:

City:

state: Zip:

phone:

e-mail:

❒ please sign me up for e-news from mGH

You can also give online at www.faustmanlab.org

please considering supporting this important research with a donation. every gift helps us get closer to achieving our goal of curing type 1 diabetes.

please support us

moving beyond insulin

ALL

mo

de

Ls u

sed

fo

r iL

Lus

tr

At

ive

pu

rp

ose

s

type 1 diabetes facts:• More than 1 million Americans live with

type 1 diabetes• There is currently no cure for diabetes,

but research is offering promise• Living with type 1 diabetes requires

using insulin therapy — for life• Type 1 diabetes shortens the average

life span by 15 years• Each year, about 30,000 Americans are

diagnosed with type 1 diabetes• Over 13,000 children are among the

newly diagnosed — 35 children each and every day

One of the most exciting things about Dr. Faustman’s research is that it makes use of a widely-used, inexpensive generic drug: BCG. Typically, generic drugs offer an affordable opportunity to expand the reach of treatment.

The use of a generic drug with a well-documented safety record like BCG also allows Dr. Faustman’s research to move quickly — in clinical trial terms — through human testing.

If the BCG therapy is effective, Dr. Faustman and her colleagues hope to bring an inexpensive treatment to many patients who will benefit tremendously.

the promise of generic drugs

“This research will attempt to reverse established diabetes, rather than simply introduce new pumps or other types of new equipment or drugs to delay the onset of diabetic complications. That is a cause for new hope and a new vision for people who already have diabetes.”

—Dr. Denise Faustman

More than 1 million Americans live with type 1 diabetes. Many of them must endure numerous injections of insulin each day in order to maintain the proper blood sugar levels.

People living with type 1 diabetes must also check their blood sugar many times each day, monitor their diet and visit the doctor frequently.

The research being conducted by Dr. Denise Faustman at Massachusetts General Hospital aims to offer a chance for people living with type 1 diabetes to move beyond managing their disease with insulin to actually reversing the condition.

The Faustman Lab is now conducting human clinical trials with Bacillus Calmette-Guérin (BCG), a generic drug that may help to remove the defective cells that cause type 1 diabetes.

Most importantly, the goal of Dr. Faustman’s clinical trials is to develop a cure for diabetes, not just manage it.

With your help, the goal of ending type 1 diabetes can be achieved.